The Emerging Role of Tertiary Lymphoid Structures as Predictive and Prognostic Biomarkers of Immunotherapy in Cancer

Key Points

• This research aims to evaluate the role of tertiary lymphoid structures as biomarkers predicting immunotherapy outcomes in cancer.
• Literature review of existing studies on tertiary lymphoid structures and immunotherapy.
• Assessment of the prognostic value of these structures.
• Identification of standardized evaluation methods for clinical application.
• Tertiary lymphoid structures show promise as biomarkers for predicting immunotherapy response.
• Standardized evaluation methods are necessary for successful implementation.
• Prospective clinical validation of these structures is essential for their use in personalized treatment strategies.